EDAP TMS S.A. (FOCL)
NASDAQ: FOCL · Real-Time Price · USD
4.570
-0.080 (-1.72%)
Jun 3, 2026, 1:52 PM EDT - Market open
EDAP TMS Revenue
EDAP TMS had revenue of $15.39M in the quarter ending March 31, 2026, with 16.68% growth. This brings the company's revenue in the last twelve months to $64.25M, up 2.97% year-over-year. In the year 2025, EDAP TMS had annual revenue of $60.11M, down -9.86%.
Revenue (ttm)
$64.25M
Revenue Growth
+2.97%
P/S Ratio
2.35
Revenue / Employee
$256,304
Employees
289
Market Cap
171.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60.11M | -6.58M | -9.86% |
| Dec 31, 2024 | 66.69M | 6.27M | 10.37% |
| Dec 31, 2023 | 60.42M | 5.32M | 9.64% |
| Dec 31, 2022 | 55.11M | 11.04M | 25.06% |
| Dec 31, 2021 | 44.07M | 2.40M | 5.77% |
| Dec 31, 2020 | 41.66M | -3.25M | -7.24% |
| Dec 31, 2019 | 44.91M | 5.73M | 14.62% |
| Dec 31, 2018 | 39.18M | 3.44M | 9.62% |
| Dec 31, 2017 | 35.75M | 135.00K | 0.38% |
| Dec 31, 2016 | 35.61M | 3.36M | 10.41% |
| Dec 31, 2015 | 32.25M | 5.47M | 20.41% |
| Dec 31, 2014 | 26.79M | 2.71M | 11.23% |
| Dec 31, 2013 | 24.08M | -1.99M | -7.62% |
| Dec 31, 2012 | 26.07M | 3.77M | 16.93% |
| Dec 31, 2011 | 22.29M | -1.42M | -5.97% |
| Dec 31, 2010 | 23.71M | -1.18M | -4.73% |
| Dec 31, 2009 | 24.89M | 1.83M | 7.95% |
| Dec 31, 2008 | 23.05M | 726.00K | 3.25% |
| Dec 31, 2007 | 22.33M | 2.06M | 10.18% |
| Dec 31, 2006 | 20.27M | -545.00K | -2.62% |
| Dec 31, 2005 | 20.81M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionFOCL News
- 5 days ago - EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy - GlobeNewsWire
- 13 days ago - EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference - GlobeNewsWire
- 20 days ago - EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer - GlobeNewsWire
- 20 days ago - EDAP | Focal One to Host Investor Day on June 1, 2026 - GlobeNewsWire
- 27 days ago - EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue - GlobeNewsWire
- 4 weeks ago - EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer - GlobeNewsWire
- 6 weeks ago - EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026 - GlobeNewsWire
- 2 months ago - EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue - GlobeNewsWire